Additional studies with nimorazole, a less efficient sensitizer but less toxic drug, in head and neck cancer patients (DAHANCA 5) showed a highly significant benefit in terms of improved locoregional tumor control and disease-free survival [ 31 ].
← all excerpts
The impact of hypoxia and its modification of the outcome of radiotherapy.
1
—
—